Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 105
interventional 84
Observational 20
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Biological 54
Drug 9
Biological|placebo 6
Other 4
Biological|Drug 2
Device 2
Dietary Supplement|placebo 2
Drug|placebo 2
Behavioral 1
Biological|Other 1
Diagnostic Test 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 9
Germany 5
NA 5
Finland 4
Czechia 3
South Africa 3
Australia 2
Belgium 2
Canada 2
Finland|France|Poland 2
Greece|Spain 2
India 2
Korea, Republic of 2
Mexico 2
Philippines|Poland 2
Spain 2
Argentina|Colombia|Panama 1
Bangladesh 1
Belgium|Canada 1
Belgium|Finland|Sweden 1
Brazil|Croatia|Egypt 1
Burkina Faso 1
Chile 1
China 1
Czechia|Germany|Poland|Spain 1
Czechia|Germany|Poland|Sweden 1
Denmark|Norway|Slovakia|Sweden 1
France 1
Gambia 1
Germany|Poland|Spain 1
Japan 1
Malawi|South Africa 1
Malaysia|Singapore 1
Mali 1
Mali|Nigeria 1
Netherlands 1
Nigeria 1
Norway 1
Poland 1
Poland|Russian Federation 1
Romania 1
Singapore 1
Slovakia|Sweden 1
Sweden 1
Switzerland 1
Taiwan 1
United Kingdom 1
United States|Australia|India|Italy|Romania|Ukraine 1
United States|Belgium|Czechia 1
United States|Canada 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 31
2 4
3 7
4 4
5 4
6 4
7 4
8 4
9 1
10 4
14 2
15 1
16 1
17 1
19 1
22 1
23 1
24 1
30 1
32 1
35 2
42 1
56 1
66 2

Phase

Phase Study_Count
Phase 3 39
Phase 2 17
N/A 12
Phase 1 11
Phase 4 3
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 11
2 29
3 11
4 10
5 4
6 2
7 3
8 2
12 1
18 1
NA 10

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 40.00 12.0000 11.00 43.0000 52.000 21.0000
1st Qu. 127.50 25.0000 103.25 163.0000 241.500 25.5000
Median 218.50 61.0000 195.50 365.0000 365.000 30.0000
Mean 17470.33 105.3636 195.50 562.8235 2245.692 300.3333
3rd Qu. 402.00 162.5000 287.75 786.0000 675.000 440.0000
Max. 206703.00 335.0000 380.00 1806.0000 41188.000 850.0000

Trial Group Type

group_type Group_Count
Experimental 162
Active Comparator 61
Placebo Comparator 14
NA 10
Other 3
No Intervention 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 66
Single Group Assignment 12
Sequential Assignment 3
NA 2
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Prevention 62
Treatment 10
Diagnostic 6
Basic Science 5
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 5
Australia 1
Belgium 1
Egypt 1
Estonia|Lithuania|Poland|Romania|Slovenia 1
Fiji 1
India 1
Israel 1
Italy 1
Korea, Republic of 1
NA 1
Panama 1
Saudi Arabia 1
Spain 1
Sweden 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 15
2 2
7 1
13 1
25 1

Enrollment Metrics

Measure Observational
Min 21.00
1st Qu 100.00
Median 525.00
Mean 647.40
3rd Qu 747.25
Max 2329.00

Observation Model

observational_model Study_Count
Cohort 7
Case-Only 4
NA 4
Other 2
Case Control 1
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 12
Cross-Sectional 3
Other 2
NA 2
Retrospective 1

Registries

Studies by Country

Country Study_Count
NA 1

Sites per Study

Site_count Study_Count
1 1

Enrollment Metrics

Measure Registries
Min 54759
1st Qu 54759
Median 54759
Mean 54759
3rd Qu 54759
Max 54759

Registry Model

observational_model Study_Count
Cohort 1

Time Perspective

time_perspective Study_Count
Other 1

Follow-up

target_duration Study_Count
20 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03361163 Controlled Human Infection for Vaccination Against Streptococcus Pyogenes https://ClinicalTrials.gov/show/NCT03361163 Completed Murdoch Childrens Research Institute 2019-09-28
NCT03171350 Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis. https://ClinicalTrials.gov/show/NCT03171350 Completed Ellume Pty Ltd 2018-08-15
NCT03170609 A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age https://ClinicalTrials.gov/show/NCT03170609 Completed Pfizer 2018-06-25
NCT02972281 Systematic Search for Primary Immunodeficiency in Adults With Infections https://ClinicalTrials.gov/show/NCT02972281 Recruiting University Hospital, Lille 2020-03-31
NCT02838407 Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. https://ClinicalTrials.gov/show/NCT02838407 Completed GlaxoSmithKline 2015-09-23
NCT02718157 Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains https://ClinicalTrials.gov/show/NCT02718157 Completed GenePOC 2017-02-07
NCT02528981 Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02528981 Completed Ryerson University 2016-06-30
NCT02447432 A Study to Compare the Immunogenicity of GSK Biologicals’ 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorixâ„¢ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants https://ClinicalTrials.gov/show/NCT02447432 Completed GlaxoSmithKline 2016-01-23
NCT02270944 Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine https://ClinicalTrials.gov/show/NCT02270944 Completed GlaxoSmithKline 2015-04-23
NCT02142933 Simplified GBS Screening and Prevalence of ESBL in Pregnant Women https://ClinicalTrials.gov/show/NCT02142933 Completed University Hospital, Basel, Switzerland 2016-11-30
NCT02052973 Efficacy of Propolis Varnish Against Oral Biofilm https://ClinicalTrials.gov/show/NCT02052973 Completed Federal University of Minas Gerais 2015-01-31
NCT01979588 How Does the Clinical Tool ‘What’s Going Around’ Affect Clinical Practice https://ClinicalTrials.gov/show/NCT01979588 Completed NorthShore University HealthSystem 2014-11-30
NCT01746108 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Pneumococcal Vaccine (Synflorixâ„¢) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection https://ClinicalTrials.gov/show/NCT01746108 Completed GlaxoSmithKline 2015-06-29
NCT01641133 Primary Vaccination With Either Synflorixâ„¢ or Prevenar 13â„¢ or Both Vaccines and Booster Vaccination With Synflorixâ„¢ https://ClinicalTrials.gov/show/NCT01641133 Completed GlaxoSmithKline 2013-07-15
NCT01616459 Immunogenicity and Safety of Two Formulations of GSK Biologicals’ Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants https://ClinicalTrials.gov/show/NCT01616459 Completed GlaxoSmithKline 2013-04-25
NCT01577108 Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women https://ClinicalTrials.gov/show/NCT01577108 Completed China Medical University Hospital 2012-09-30
NCT01545375 Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children https://ClinicalTrials.gov/show/NCT01545375 Completed GlaxoSmithKline 2016-07-26
NCT01485406 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ Pneumococcal Vaccine 2830930A Administered in Toddlers https://ClinicalTrials.gov/show/NCT01485406 Completed GlaxoSmithKline 2012-03-15
NCT03348618 A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) https://ClinicalTrials.gov/show/NCT03348618 Active, not recruiting IMMUNOe Research Centers 2019-11-30
NCT01446289 Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings https://ClinicalTrials.gov/show/NCT01446289 Completed Novartis 2013-04-30
NCT01412801 Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings https://ClinicalTrials.gov/show/NCT01412801 Completed Novartis 2012-10-31
NCT04100772 Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above https://ClinicalTrials.gov/show/NCT04100772 Recruiting CanSino Biologics Inc. 2020-10-01
NCT03807245 Group B Streptococcus Vaccine in Healthy Females https://ClinicalTrials.gov/show/NCT03807245 Completed Minervax ApS 2019-10-14
NCT03765073 Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants https://ClinicalTrials.gov/show/NCT03765073 Recruiting Pfizer 2022-05-31
NCT03669094 Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women https://ClinicalTrials.gov/show/NCT03669094 Recruiting ProbiSearch SL 2020-09-30
NCT01262872 Impact of GSK Biologicals’ 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants https://ClinicalTrials.gov/show/NCT01262872 Completed GlaxoSmithKline 2013-03-18
NCT01235949 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment https://ClinicalTrials.gov/show/NCT01235949 Completed GlaxoSmithKline 2012-03-28
NCT01204658 Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants https://ClinicalTrials.gov/show/NCT01204658 Completed GlaxoSmithKline 2011-11-03
NCT01193920 Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age https://ClinicalTrials.gov/show/NCT01193920 Completed Novartis 2011-12-31
NCT01175083 Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A https://ClinicalTrials.gov/show/NCT01175083 Completed GlaxoSmithKline 2013-01-17
NCT01156740 Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings https://ClinicalTrials.gov/show/NCT01156740 Completed Johns Hopkins University 2003-04-30
NCT01153893 Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria https://ClinicalTrials.gov/show/NCT01153893 Completed GlaxoSmithKline 2011-02-16
NCT01153841 Primary Vaccination Study With GSK Biologicals’ Pneumococcal Vaccine in Healthy Infants in Vietnam https://ClinicalTrials.gov/show/NCT01153841 Completed GlaxoSmithKline 2011-07-26
NCT01119625 Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose https://ClinicalTrials.gov/show/NCT01119625 Completed GlaxoSmithKline 2011-02-17
NCT01118143 Oral Health Literacy Tailored Communication https://ClinicalTrials.gov/show/NCT01118143 Completed University of Tromso 2012-02-29
NCT01030822 Booster and Catch-up Vaccination With Vaccine GSK1024850A https://ClinicalTrials.gov/show/NCT01030822 Completed GlaxoSmithKline 2011-08-19
NCT01030731 Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease https://ClinicalTrials.gov/show/NCT01030731 Completed Basilea Pharmaceutica 2007-08-31
NCT01027845 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children https://ClinicalTrials.gov/show/NCT01027845 Completed GlaxoSmithKline 2010-08-13
NCT01026740 Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01026740 Completed Basilea Pharmaceutica 2007-09-30
NCT01026636 A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age https://ClinicalTrials.gov/show/NCT01026636 Completed Basilea Pharmaceutica 2010-04-30
NCT01026558 A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients https://ClinicalTrials.gov/show/NCT01026558 Completed Basilea Pharmaceutica 2007-11-30
NCT00985751 Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination https://ClinicalTrials.gov/show/NCT00985751 Completed GlaxoSmithKline 2010-10-12
NCT00985465 Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali https://ClinicalTrials.gov/show/NCT00985465 Completed GlaxoSmithKline 2010-06-26
NCT00950833 Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children https://ClinicalTrials.gov/show/NCT00950833 Completed GlaxoSmithKline 2010-09-16
NCT00911144 Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine https://ClinicalTrials.gov/show/NCT00911144 Completed GlaxoSmithKline 2010-01-11
NCT00907777 Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23â„¢ https://ClinicalTrials.gov/show/NCT00907777 Completed GlaxoSmithKline 2009-10-05
NCT00896064 Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults https://ClinicalTrials.gov/show/NCT00896064 Completed GlaxoSmithKline 2009-08-05
NCT00861380 Evaluation of Effectiveness of GSK Biologicals’ Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease https://ClinicalTrials.gov/show/NCT00861380 Completed GlaxoSmithKline 2012-01-31
NCT00839254 Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals’ Pneumococcal Conjugate Vaccine 1024850A https://ClinicalTrials.gov/show/NCT00839254 Completed GlaxoSmithKline 2012-01-31
NCT00829010 Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. https://ClinicalTrials.gov/show/NCT00829010 Completed GlaxoSmithKline 2011-06-13
NCT00814710 Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age https://ClinicalTrials.gov/show/NCT00814710 Completed GlaxoSmithKline 2009-11-13
NCT00808444 Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age https://ClinicalTrials.gov/show/NCT00808444 Completed GlaxoSmithKline 2009-11-02
NCT00792909 Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A https://ClinicalTrials.gov/show/NCT00792909 Completed GlaxoSmithKline 2009-07-02
NCT00756067 Evaluation of Pneumococcal Vaccine Formulations in Elderly https://ClinicalTrials.gov/show/NCT00756067 Completed GlaxoSmithKline 2009-05-28
NCT00707798 Evaluation of Pneumococcal Vaccine Formulations in Young Adults https://ClinicalTrials.gov/show/NCT00707798 Completed GlaxoSmithKline 2009-01-15
NCT00680914 Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenarâ„¢ and Hiberixâ„¢ https://ClinicalTrials.gov/show/NCT00680914 Completed GlaxoSmithKline 2009-05-08
NCT00678301 Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrixâ„¢ Hib and Polio Sabinâ„¢ https://ClinicalTrials.gov/show/NCT00678301 Completed GlaxoSmithKline 2009-11-09
NCT00652951 Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib https://ClinicalTrials.gov/show/NCT00652951 Completed GlaxoSmithKline 2009-05-12
NCT00646958 Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections https://ClinicalTrials.gov/show/NCT00646958 Completed Melinta Therapeutics, Inc. 2008-04-30
NCT00624819 Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00624819 Completed GlaxoSmithKline 2008-06-02
NCT00609492 Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. https://ClinicalTrials.gov/show/NCT00609492 Completed GlaxoSmithKline 2008-11-10
NCT00547248 Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines https://ClinicalTrials.gov/show/NCT00547248 Completed GlaxoSmithKline 2008-05-10
NCT00527852 Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis https://ClinicalTrials.gov/show/NCT00527852 Completed Children’s Hospital of Eastern Ontario 2007-12-31
NCT00514527 A Study for Patients With Complicated Skin and Skin Structure Infections https://ClinicalTrials.gov/show/NCT00514527 Completed Targanta Therapeutics Corporation 2008-04-30
NCT00513409 Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule https://ClinicalTrials.gov/show/NCT00513409 Completed GlaxoSmithKline 2008-02-20
NCT00496015 Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A https://ClinicalTrials.gov/show/NCT00496015 Completed GlaxoSmithKline 2008-03-25
NCT00489554 Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age https://ClinicalTrials.gov/show/NCT00489554 Completed GlaxoSmithKline 2008-03-31
NCT00466947 COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00466947 Completed GlaxoSmithKline 2010-08-31
NCT00390910 Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants https://ClinicalTrials.gov/show/NCT00390910 Completed GlaxoSmithKline 2007-07-02
NCT00370396 Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine. https://ClinicalTrials.gov/show/NCT00370396 Completed GlaxoSmithKline 2007-06-04
NCT00370227 Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00370227 Completed GlaxoSmithKline NA
NCT00345358 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00345358 Completed GlaxoSmithKline 2007-11-15
NCT00344318 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00344318 Completed GlaxoSmithKline 2007-04-27
NCT00334334 Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-valent Pneumococcal Conjugate Vaccine. https://ClinicalTrials.gov/show/NCT00334334 Completed GlaxoSmithKline 2007-07-31
NCT00333450 Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. https://ClinicalTrials.gov/show/NCT00333450 Completed GlaxoSmithKline NA
NCT00327665 Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population https://ClinicalTrials.gov/show/NCT00327665 Completed GlaxoSmithKline 2007-01-01
NCT00307554 A Lot-to-lot Consistency (3 Lots of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study https://ClinicalTrials.gov/show/NCT00307554 Completed GlaxoSmithKline NA
NCT00307541 Assess the Immunogenicity of GSK Biologicals’ 10-valent Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00307541 Completed GlaxoSmithKline 2006-04-07
NCT00307034 Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule https://ClinicalTrials.gov/show/NCT00307034 Completed GlaxoSmithKline 2007-01-01
NCT00169481 A Study in Children With Different Formulations of GSK Biologicals’ 11 Valent Pneumococcal Conjugate Vaccine https://ClinicalTrials.gov/show/NCT00169481 Completed GlaxoSmithKline 2005-05-31
NCT00138112 Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation https://ClinicalTrials.gov/show/NCT00138112 Completed Memorial Sloan Kettering Cancer Center NA
NCT00128219 Prevention of GBS Colonization Via Immunity https://ClinicalTrials.gov/show/NCT00128219 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-12-31
NCT00001658 Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections https://ClinicalTrials.gov/show/NCT00001658 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001359 Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) https://ClinicalTrials.gov/show/NCT00001359 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03055728 Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis https://ClinicalTrials.gov/show/NCT03055728 Completed Georgetown University 2018-01-16
NCT02889016 Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS https://ClinicalTrials.gov/show/NCT02889016 Recruiting Stanford University 2028-03-31
NCT02190292 PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort https://ClinicalTrials.gov/show/NCT02190292 Completed Karolinska Institutet 2017-06-30
NCT01793857 Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama https://ClinicalTrials.gov/show/NCT01793857 Completed GlaxoSmithKline 2013-05-31
NCT01445717 Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy https://ClinicalTrials.gov/show/NCT01445717 Completed The University of Texas Health Science Center, Houston 2012-11-30
NCT01434719 Human Suis and Pig Diseases in Northern Vietnam https://ClinicalTrials.gov/show/NCT01434719 Completed Oxford University Clinical Research Unit, Vietnam 2011-12-31
NCT01365390 To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries https://ClinicalTrials.gov/show/NCT01365390 Completed GlaxoSmithKline 2012-12-31
NCT04038073 TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study https://ClinicalTrials.gov/show/NCT04038073 Recruiting University of Turin, Italy 2020-06-30
NCT03777098 Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis https://ClinicalTrials.gov/show/NCT03777098 Recruiting Olive View-UCLA Education & Research Institute 2020-11-30
NCT03671486 Colonization With Group B Streptococcus During Pregnancy https://ClinicalTrials.gov/show/NCT03671486 Recruiting ProbiSearch SL 2020-09-30
NCT01248988 Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea https://ClinicalTrials.gov/show/NCT01248988 Completed GlaxoSmithKline 2015-09-30
NCT01204385 Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia https://ClinicalTrials.gov/show/NCT01204385 Completed GlaxoSmithKline 2011-05-31
NCT00884728 Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia’s Northern Territory https://ClinicalTrials.gov/show/NCT00884728 Completed Menzies School of Health Research 2007-08-31
NCT01441479 Strep A Fluorescent Immunoassay and Analyzer Field Study https://ClinicalTrials.gov/show/NCT01441479 Completed Quidel Corporation 2012-12-31
NCT04227730 MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY https://ClinicalTrials.gov/show/NCT04227730 Recruiting Fayoum University Hospital 2020-06-30
NCT00637351 A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays https://ClinicalTrials.gov/show/NCT00637351 Completed GlaxoSmithKline 2009-02-28
NCT00523770 Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae https://ClinicalTrials.gov/show/NCT00523770 Completed GlaxoSmithKline 2007-09-30
NCT00436891 Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji https://ClinicalTrials.gov/show/NCT00436891 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00342199 Surveillance of Streptococcal Infections in Children in India https://ClinicalTrials.gov/show/NCT00342199 Completed National Institutes of Health Clinical Center (CC) NA
NCT00299663 Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract https://ClinicalTrials.gov/show/NCT00299663 Completed Hadassah Medical Organization NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04222907 The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel https://ClinicalTrials.gov/show/NCT04222907 Completed Assuta Hospital Systems 2016-09-20